|
Volumn 63, Issue 6, 2014, Pages 1829-1830
|
DPP-4 inhibitors-renoprotection in diabetic nephropathy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CATION INDEPENDENT MANNOSE 6 PHOSPHATE RECEPTORE;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GLUCOSE;
LINAGLIPTIN;
MICRORNA 200;
MICRORNA 21;
MICRORNA 29;
RECEPTOR;
STREPTOZOCIN;
TRANSFORMING GROWTH FACTOR BETA;
UNCLASSIFIED DRUG;
APICAL MEMBRANE;
BLOOD PRESSURE REGULATION;
CEREBROVASCULAR ACCIDENT;
CLINICAL EVALUATION;
DIABETIC NEPHROPATHY;
DIABETIC PATIENT;
DRUG EFFICACY;
DRUG HALF LIFE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEART INFARCTION;
HOSPITALIZATION;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY FAILURE;
KIDNEY FIBROSIS;
KIDNEY PROXIMAL TUBULE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PODOCYTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
RENAL PROTECTION;
SIGNAL TRANSDUCTION;
UNSTABLE ANGINA PECTORIS;
ANIMALS;
DIABETIC NEPHROPATHIES;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
ENDOTHELIAL CELLS;
MALE;
MESENCHYMAL STROMAL CELLS;
PURINES;
QUINAZOLINES;
|
EID: 84901303279
PISSN: 00121797
EISSN: 1939327X
Source Type: Journal
DOI: 10.2337/db14-0366 Document Type: Note |
Times cited : (20)
|
References (5)
|